Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

Presentation NY Valves 2024

Cinching the Dilated LV From the Coronary Sinus Using the CARILLON Device

Presenter: Samir R. Kapadia

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

"Challenge Is Inevitable But Defeat Is Optional" – A Case of TAVR in Very Small Anatomy With an Anomalous Origin of Both Coronary Arteries From a Single Sinus

Presenter: Prashant Dwivedi

June 05, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

Advertisement

November 2024 Dispatch for the CV Team

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Going Contrast Free in TAVI Is Safe for CKD Patients

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Cinching the Dilated LV From the Coronary Sinus Using the CARILLON Device

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

"Challenge Is Inevitable But Defeat Is Optional" – A Case of TAVR in Very Small Anatomy With an Anomalous Origin of Both Coronary Arteries From a Single Sinus

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content